• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CU6 1.08% $3.65

CLARITY PHARMACEUTICALS LTD

Clarity Pharmaceuticals Ltd is an Australia-based clinical-stage radiopharmaceutical... Clarity Pharmaceuticals Ltd is an Australia-based clinical-stage radiopharmaceutical company. The Company is focused on developing theranostic (therapy and imaging) products, based on its platform SAR Technology. It is progressing seven clinical trials with its three key products, SARTATE, SAR-bisPSMA, and SAR-Bombesin. SARTATE is developed for diagnosing, staging, and treating cancers that express somatostatin receptor 2 (SSTR2), including neuroblastoma and neuroendocrine tumors (NETs). SAR-bisPSMA is developed for diagnosing, staging, and treating cancers that express Prostate Specific Membrane Antigen (PSMA). SAR-Bombesin is developed for identifying and selecting patients for subsequent treatment of cancers that express a specific receptor called the gastrin releasing peptide receptor (GRPr), including breast cancer and prostate cancer. It has a diverse range of products in clinical trials, which address both large indications as well as rare and orphan indications of cancer.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CU6
CU6 - ASX Charts
26 27 28
09/02/25 1.6K 638K
09/02/25 Last post  MJ07 Comments Created with Sketch.  1.6K  Views Created with Sketch.  638K 
CU6 06/02/25 95 29K
06/02/25 Last post  cpt_yossarian Comments Created with Sketch.  95  Views Created with Sketch.  29K 
CU6 03/02/25 70 22K
03/02/25 Last post  ttppxx Comments Created with Sketch.  70  Views Created with Sketch.  22K 
CU6
CU6 - Media and Industry News
12 13 14
02/02/25 815 357K
02/02/25 Last post  jinvstr Comments Created with Sketch.  815  Views Created with Sketch.  357K 
CU6 02/02/25 17 6.1K
02/02/25 Last post  fourdollars Comments Created with Sketch.  17  Views Created with Sketch.  6.1K 
CU6
Lost +$1B MC When….
31/01/25 0 476
31/01/25 Last post  rolling Comments Created with Sketch.  0  Views Created with Sketch.  476 
CU6
Short Interest
29/01/25 1 629
29/01/25 Last post  slick Comments Created with Sketch.  1  Views Created with Sketch.  629 
CU6 29/01/25 0 347
29/01/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  347 

See All Discussions arrow Created with Sketch.

Timeline

Quarterly Activities/Appendix 4C Cash Flow Report
31 Jan 11:57
 
Cleansing Notice
29 Jan 18:54
 
Application for quotation of securities - CU6
29 Jan 18:48
 
Clarity to present COBRA and CLARIFY abstracts
28 Jan 09:37
 
Clarity receives U.S. FDA Fast Track Designation
24 Jan 09:40
 
Cleansing Notice
22 Jan 15:46
 
View More arrow Created with Sketch.
(20min delay)
Last
$3.65
Change
-0.040(1.08%)
Mkt cap ! $1.180B
Open High Low Value Volume
$3.66 $3.70 $3.57 $2.111M 579.5K

Buyers (Bids)

No. Vol. Price($)
15 8788 $3.64
 

Sellers (Offers)

Price($) Vol. No.
$3.66 6608 24
View Market Depth
Last trade - 15.17pm 10/02/2025 (20 minute delay) ?
Last
$3.65
  Change
-0.040 ( 0.55 %)
Open High Low Volume
$3.65 $3.70 $3.57 114687
Last updated 15.34pm 10/02/2025 ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.